(Q54274429)

English

Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

primary sclerosing cholangitis

1 reference

based on heuristic

inferred from title

object named as

Noam Harpaz

5

0 references

Jean-Frédéric Colombel

14

object named as

Jean-Frédéric Colombel

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

author name string

Joana Torres

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Xiuliang Bao

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Alina C Iuga

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Anli Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Thomas Ullman

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Benjamin L Cohen

7

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Guillaume Pineton de Chambrun

8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Stefania Asciutti

9

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Joseph A Odin

10

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

David B Sachar

11

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

H Rex Gaskins

12

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Kenneth Setchell

13

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Steven H Itzkowitz

15

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

19

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

275-282

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Intestinal inflammation and cancer

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Bile acids and colon cancer: Solving the puzzle with nuclear receptors

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

The bile acid receptor FXR is a modulator of intestinal innate immunity

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Nuclear bile acid receptor FXR protects against intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318286FF2E

21 January 2018

Identifiers

10.1097/MIB.0B013E318286FF2E

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23348121

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54274429&oldid=1531581085"